
### [NCIT:C3483](http://purl.obolibrary.org/obo/NCIT_C3483)
**Label:** Chronic Leukemia

**Subclasses:** [NCIT:C7847](http://purl.obolibrary.org/obo/NCIT_C7847) (Stage 0 Chronic Lymphocytic Leukemia), [NCIT:C7886](http://purl.obolibrary.org/obo/NCIT_C7886) (Refractory Chronic Lymphocytic Leukemia), [NCIT:C7402](http://purl.obolibrary.org/obo/NCIT_C7402) (Hairy Cell Leukemia), [NCIT:C4752](http://purl.obolibrary.org/obo/NCIT_C4752) (T-Cell Prolymphocytic Leukemia), [NCIT:C4753](http://purl.obolibrary.org/obo/NCIT_C4753) (B-Cell Prolymphocytic Leukemia), [NCIT:C45264](http://purl.obolibrary.org/obo/NCIT_C45264) (Cutaneous Chronic Lymphocytic Leukemia), [NCIT:C7300](http://purl.obolibrary.org/obo/NCIT_C7300) (Splenic Manifestation of Chronic Lymphocytic Leukemia), [NCIT:C7302](http://purl.obolibrary.org/obo/NCIT_C7302) (Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia), [NCIT:C7401](http://purl.obolibrary.org/obo/NCIT_C7401) (Hairy Cell Leukemia Variant), [NCIT:C7301](http://purl.obolibrary.org/obo/NCIT_C7301) (Splenic Manifestation of Hairy Cell Leukemia), [NCIT:C3181](http://purl.obolibrary.org/obo/NCIT_C3181) (Prolymphocytic Leukemia), [NCIT:C36270](http://purl.obolibrary.org/obo/NCIT_C36270) (T-Cell Prolymphocytic Leukemia, Small Cell Variant), [NCIT:C3163](http://purl.obolibrary.org/obo/NCIT_C3163) (Chronic Lymphocytic Leukemia), [NCIT:C3179](http://purl.obolibrary.org/obo/NCIT_C3179) (Chronic Neutrophilic Leukemia), [NCIT:C7876](http://purl.obolibrary.org/obo/NCIT_C7876) (Stage III Chronic Lymphocytic Leukemia), [NCIT:C8647](http://purl.obolibrary.org/obo/NCIT_C8647) (Aggressive NK-Cell Leukemia), [NCIT:C7875](http://purl.obolibrary.org/obo/NCIT_C7875) (Stage II Chronic Lymphocytic Leukemia), [NCIT:C4664](http://purl.obolibrary.org/obo/NCIT_C4664) (T-Cell Large Granular Lymphocyte Leukemia), [NCIT:C8029](http://purl.obolibrary.org/obo/NCIT_C8029) (Progressive Hairy Cell Leukemia Initial Treatment), [NCIT:C8645](http://purl.obolibrary.org/obo/NCIT_C8645) (Recurrent Chronic Lymphocytic Leukemia), [NCIT:C8646](http://purl.obolibrary.org/obo/NCIT_C8646) (Stage IV Chronic Lymphocytic Leukemia), [NCIT:C7299](http://purl.obolibrary.org/obo/NCIT_C7299) (Splenic Manifestation of B-Cell Prolymphocytic Leukemia), [NCIT:C7874](http://purl.obolibrary.org/obo/NCIT_C7874) (Stage I Chronic Lymphocytic Leukemia), [NCIT:C4563](http://purl.obolibrary.org/obo/NCIT_C4563) (Chronic Eosinophilic Leukemia, Not Otherwise Specified), [NCIT:C3175](http://purl.obolibrary.org/obo/NCIT_C3175) (Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C7298](http://purl.obolibrary.org/obo/NCIT_C7298) (Splenic Manifestation of T-Cell Prolymphocytic Leukemia), [NCIT:C7176](http://purl.obolibrary.org/obo/NCIT_C7176) (Aleukemic Chronic Lymphocytic Leukemia), [NCIT:C7297](http://purl.obolibrary.org/obo/NCIT_C7297) (Splenic Manifestation of Prolymphocytic Leukemia), [NCIT:C39586](http://purl.obolibrary.org/obo/NCIT_C39586) (T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta), [NCIT:C8030](http://purl.obolibrary.org/obo/NCIT_C8030) (Refractory Hairy Cell Leukemia), [NCIT:C36272](http://purl.obolibrary.org/obo/NCIT_C36272) (Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation), [NCIT:C36271](http://purl.obolibrary.org/obo/NCIT_C36271) (T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant), [NCIT:C37202](http://purl.obolibrary.org/obo/NCIT_C37202) (Chronic Lymphocytic Leukemia with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation), [NCIT:C39584](http://purl.obolibrary.org/obo/NCIT_C39584) (T-Cell Large Granular Lymphocyte Leukemia, Common Variant), [NCIT:C126351](http://purl.obolibrary.org/obo/NCIT_C126351) (Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA), [NCIT:C37205](http://purl.obolibrary.org/obo/NCIT_C37205) (Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene), 

**Class expressions from DL-Learner:**

- Thing 51.96%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40199](http://purl.obolibrary.org/obo/NCIT_C40199) (Cervical Squamous Intraepithelial Neoplasia 1))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40198](http://purl.obolibrary.org/obo/NCIT_C40198) (Cervical Squamous Intraepithelial Neoplasia 2))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40194](http://purl.obolibrary.org/obo/NCIT_C40194) (Cervical Squamotransitional Carcinoma))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40193](http://purl.obolibrary.org/obo/NCIT_C40193) (Cervical Lymphoepithelioma-Like Carcinoma))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40191](http://purl.obolibrary.org/obo/NCIT_C40191) (Cervical Warty Carcinoma))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40190](http://purl.obolibrary.org/obo/NCIT_C40190) (Cervical Verrucous Carcinoma))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4019](http://purl.obolibrary.org/obo/NCIT_C4019) (Paget Disease and Intraductal Carcinoma of the Breast))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40189](http://purl.obolibrary.org/obo/NCIT_C40189) (Cervical Basaloid Carcinoma))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40187](http://purl.obolibrary.org/obo/NCIT_C40187) (Cervical Keratinizing Squamous Cell Carcinoma))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40182](http://purl.obolibrary.org/obo/NCIT_C40182) (Uterine Corpus Carcinofibroma))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40177](http://purl.obolibrary.org/obo/NCIT_C40177) (Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40175](http://purl.obolibrary.org/obo/NCIT_C40175) (Uterine Corpus Myxoid Leiomyosarcoma))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40174](http://purl.obolibrary.org/obo/NCIT_C40174) (Uterine Corpus Epithelioid Leiomyosarcoma))) 43.69%


